2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide

C10H14N6O2S — CID 63303237

IUPAC2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide
SMILESCn1nccc1CNS(=O)(=O)c1cccnc1NN
InChIInChI=1S/C10H14N6O2S/c1-16-8(4-6-13-16)7-14-19(17,18)9-3-2-5-12-10(9)15-11/h2-6,14H,7,11H2,1H3,(H,12,15)
InChIKeyICRQPZNKKVXWBZ-UHFFFAOYSA-N
MW282.33 g/mol
LogP-0.42
Rot. Bonds5

About 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide

2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide (PubChem CID 63303237) has the molecular formula C10H14N6O2S and a molecular weight of 282.33 g/mol. Its IUPAC name is 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide.

Molecular Properties

Compound Name2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide
PubChem CID63303237
Molecular FormulaC10H14N6O2S
Molecular Weight282.33 g/mol
Exact Mass282.09
IUPAC Name2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide
SMILESCn1nccc1CNS(=O)(=O)c1cccnc1NN
InChIInChI=1S/C10H14N6O2S/c1-16-8(4-6-13-16)7-14-19(17,18)9-3-2-5-12-10(9)15-11/h2-6,14H,7,11H2,1H3,(H,12,15)
InChIKeyICRQPZNKKVXWBZ-UHFFFAOYSA-N
XLogP-0.42
TPSA114.93 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms19
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500282.33
LogP ≤ 5-0.42
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[(2-methylpyrazol-3-yl)methylsulfamoyl]pyridine-2-carbothioamide
CID 106597314
N-[(2-ethylphenyl)methyl]-2-hydrazinylpyridine-3-sulfonamide
CID 64694908
2-(methylaminomethyl)-N-[(2-methylpyrazol-3-yl)methyl]benzenesulfonamide
CID 106065065
2-hydrazinyl-N-(1,2-oxazol-5-ylmethyl)pyridine-3-sulfonamide
CID 106419554
3-bromo-2-methyl-N-[(2-methylpyrazol-3-yl)methyl]benzenesulfonamide
CID 71982239
2-hydrazinyl-N-[(5-methylpyrazin-2-yl)methyl]pyridine-3-sulfonamide
CID 62848316
N-[(2-bromophenyl)methyl]-2-hydrazinylpyridine-3-sulfonamide
CID 61413878
2-[(2-hydrazinyl-3-pyridinyl)sulfonylamino]acetamide
CID 43545765
5-amino-2,4-difluoro-N-[(2-methylpyrazol-3-yl)methyl]benzenesulfonamide
CID 63304324
5-amino-2-bromo-N-[(2-methylpyrazol-3-yl)methyl]benzenesulfonamide
CID 65206650
N-[(3-chlorophenyl)methyl]-2-hydrazinylpyridine-3-sulfonamide
CID 62532935
3-[(2-hydrazinyl-3-pyridinyl)sulfonylamino]-2,2-dimethylpropanamide
CID 106278324

Frequently Asked Questions

What is the IUPAC name of 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide?
The IUPAC name of 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide (CID 63303237) is 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide.
What is the SMILES notation for 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide?
The canonical SMILES for 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide is Cn1nccc1CNS(=O)(=O)c1cccnc1NN.
What is the InChIKey of 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide?
The InChIKey is ICRQPZNKKVXWBZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C10H14N6O2S/c1-16-8(4-6-13-16)7-14-19(17,18)9-3-2-5-12-10(9)15-11/h2-6,14H,7,11H2,1H3,(H,12,15).
What are the key properties of 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide?
2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide has a molecular weight of 282.33 g/mol, XLogP of -0.42, 5 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-hydrazinyl-N-[(2-methylpyrazol-3-yl)methyl]pyridine-3-sulfonamide is sourced from PubChem (CID 63303237), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).